SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.960
+0.340 (9.39%)
At close: May 13, 2026, 4:00 PM EDT
3.900
-0.060 (-1.52%)
After-hours: May 13, 2026, 6:54 PM EDT
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $278.29 million as of May 13, 2026. Its market cap has increased by 1,573.82% in one year.
Market Cap
278.29M
Enterprise Value
177.07M
1-Year Change
1,573.82%
Ranking
Category
Stock Price
$3.96
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has increased from $130.75M to $278.29M, an increase of 112.83%. That is a compound annual growth rate of 15.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 254.40M | 42.88% |
| Dec 31, 2025 | 178.05M | 408.46% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foghorn Therapeutics | 255.99M |
| Coherus Oncology | 255.23M |
| Milestone Pharmaceuticals | 253.05M |
| Cartesian Therapeutics | 251.21M |
| Cybin | 249.68M |
| LENZ Therapeutics | 248.95M |
| Voyager Therapeutics | 248.33M |
| Fate Therapeutics | 247.68M |